How varenicline helps reduce cigarette cravings and quit smoking

Australia's adult smoking rate has dropped to roughly one in nine people, yet tens of thousands of Melbourne office workers, Sydney tradies and Brisbane hospitality staff still reach for a cigarette each morning. For many, willpower alone has failed repeatedly, and nicotine patches or gum do not dull the urge strongly enough. Varenicline, sold in Australia as Champix, has become one of the most prescribed pharmaceutical aids for adults wanting to break the habit for good.

The medication works differently from nicotine replacement products. Instead of feeding the body a steady stream of nicotine, varenicline partially switches on the same brain receptors that nicotine normally triggers. The result is a calmer baseline of satisfaction and a noticeably weaker pull when a smoker sees a pack on the counter at a pub in Adelaide or while waiting for a train in Perth.

In clinical trials, varenicline has consistently produced the highest quit rates among prescription therapies, often doubling the success seen with willpower or over-the-counter patches. It is approved by the Therapeutic Goods Administration and listed on the Pharmaceutical Benefits Scheme, which means most Australian adults can access it at a reduced cost with a valid prescription from their GP.

This article looks at the science behind varenicline, the real-world results people see, how it compares with other quit methods, what dosing looks like in practice, the Australian access pathway, and the side effects worth knowing.

How varenicline targets nicotine receptors

Varenicline is classified as a partial nicotinic acetylcholine receptor agonist, a phrase that sounds dense but describes a fairly straightforward idea. The brain has docking sites for nicotine, and when nicotine arrives, those sites flood with the reward signal that makes smoking feel pleasurable. Varenicline binds to the same sites and activates them gently, enough to soften withdrawal but not enough to produce a full nicotine high.

By partially occupying the receptors, the medication also blocks nicotine itself from latching on as strongly. This dual action explains why many people on varenicline describe cigarettes tasting strange or flat after a week of treatment. The brain no longer receives the satisfying jolt it expects, so the usual reinforcement loop begins to weaken.

This mechanism helps with both halves of nicotine dependence: the physical withdrawal causing headaches, irritability and poor sleep, and the psychological reward that keeps smokers reaching for another cigarette after dinner or during a stressful shift at a warehouse in Western Sydney. By addressing both pathways at once, varenicline can make the first two to three weeks of a quit attempt noticeably easier.

What clinical trials have shown

The evidence supporting varenicline is among the strongest of any smoking cessation medication. Head-to-head studies funded through the National Tobacco Strategy have repeatedly shown that varenicline users achieve higher continuous abstinence rates at six and twelve months than those using nicotine patches, lozenges or bupropion. In many trials, roughly one in three varenicline users remained smoke-free at the six-month mark, compared with about one in five using patches.

Real-world Australian data paints a similar picture. Quitline counsellors in Melbourne and Sydney often report that callers prescribed varenicline stay engaged with the program for longer and are more likely to set a quit date within the first fortnight. The medication appears particularly helpful for heavy smokers who have cycled through nicotine replacement therapy several times without lasting success.

It is worth noting that varenicline is not a magic pill. The strongest outcomes come when combined with behavioural support, such as the free counselling offered by Quitline Australia or follow-up appointments with a GP. Used alone, the medication still helps, but structured advice tends to lift long-term success rates further.

Comparing varenicline with other quit methods

Nicotine patches, lozenges, gums and inhalers remain the most accessible options, partly because they can be bought over the counter without a prescription at pharmacies across Australia. They work by replacing some of the nicotine the body is missing, which eases withdrawal but does little for the rewarding sensation of lighting up. For light smokers, this trade-off is often enough.

Bupropion is another PBS-listed prescription alternative with a solid track record, though it tends to produce more sleep disturbance and dry mouth than varenicline. Many GPs in Brisbane and Adelaide prefer to start with varenicline for patients who have already tried NRT unsuccessfully, because the evidence for second-line success is more robust with varenicline.

E-cigarettes occupy a separate category. They are not approved therapeutic goods in Australia and cannot be marketed as quit aids, although some adults use them as a harm-reduction tool. Compared with varenicline, vaping lacks the long-term safety data regulators require, and the nicotine content varies widely between products sold through tobacconists and convenience stores. For anyone looking for a clinically supported route, varenicline remains the prescription option with the deepest evidence base.

Dosing, timing and practical tips

Varenicline is taken as a tablet twice daily, usually starting at a low dose that is built up over the first week. The standard titration schedule begins at 0.5 mg once daily, then 0.5 mg twice daily, before reaching the maintenance dose of 1 mg twice daily from day eight onwards. Most prescribers recommend setting a quit date during the second week of treatment, once the medication has reached steady levels in the bloodstream.

The tablets can be taken with or without food, although taking them with a meal and a full glass of water helps reduce nausea, the most common side effect. Swallowing them whole is important, because the dose is calibrated for slow absorption. Many Australian pharmacists offer a free MedsCheck when the first prescription is filled, a good opportunity to ask about timing around shift work or travel between states.

Setting a concrete plan for the quit date tends to improve outcomes. Some people choose a meaningful date, like a birthday, while others pick a Monday at the start of a quieter work fortnight. Combining the medication with a written list of personal smoking triggers and a small reward for each smoke-free week is a simple but effective tactic that many Quitline advisers recommend.

Access, affordability and the Australian pathway

Varenicline was temporarily unavailable in Australia during a manufacturing disruption in 2021, but it has since returned to widespread stock at community pharmacies. Under the Pharmaceutical Benefits Scheme, the medication is subsidised for adult smokers enrolled in a cessation support program, such as Quitline or a GP-led quit plan. Once a household reaches the PBS safety net threshold, the cost drops further.

For people whose local pharmacy does not keep varenicline on the shelf, most chemists in capital cities can order it in within twenty-four to forty-eight hours. Telehealth prescriptions have also become a common pathway, particularly for residents of regional towns in Queensland or Tasmania who find it harder to attend in-person appointments.

Cost comparisons often come up during these consultations. The conversation about the pros and cons of buying generic vs branded medicines is relevant here, because both branded Champix and generic varenicline contain the same active ingredient and meet identical TGA quality standards. Choosing the generic version is usually cheaper once a private script is filled outside the PBS subsidy.

Side effects, interactions and who should avoid it

Most people tolerate varenicline well, but some experience nausea, vivid dreams, insomnia or dry mouth during the first two weeks. These effects are usually mild and fade as the body adjusts. Taking the tablet with food and a full glass of water often settles the nausea. If vivid dreams become distressing, taking the evening dose slightly earlier can help.

A small number of users report mood changes, including unusual irritability or low mood. Health professionals are advised to monitor anyone with a history of depression or anxiety closely, although the link between varenicline and serious psychiatric events remains debated in the literature. Anyone experiencing sudden changes in mood, behaviour or thinking should contact their GP promptly.

Varenicline is not recommended for people under eighteen, pregnant women, or those with severe kidney impairment unless a specialist is closely involved. It can interact with alcohol, so patients are usually advised to limit drinking during the first weeks of treatment. For those managing other health concerns, an online generic aleve option can be discussed with a pharmacist during a broader medication review, since combining over-the-counter products with prescription medicines deserves professional input. Concerns about related side effects, such as hair thinning during a stressful quit attempt, can be raised during a MedsCheck, and products from the hair loss range may be worth exploring once the worst of the withdrawal phase has passed.

Varenicline remains one of the most effective tools available for Australian adults who want to stop smoking. Speak with a GP or pharmacist this week to see whether a prescription is the right next step, and reach out to Quitline on 13 7848 for free, confidential support throughout the quit journey.